Dyne Therapeutics, Inc. (DYN)

Latest Insider Confidence Score

2026Q1

50.2
Bullish

Company insider confidence (by quarter)

2020Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Kersten Dirk Director 5,786,435 Nov 15, 2024
Ra Capital Management, L.P. 10% Owner 2,145,045 Sep 23, 2020
Kolchinsky Peter 10% Owner 2,145,045 Sep 23, 2020
Shah Rajeev M. 10% Owner 2,145,045 Sep 23, 2020
Forbion Capital Fund IV Cooperatief U.A. — 1,608,786 Sep 23, 2020

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 5, 2026 Mar 6, 2026 Friedl-Naderer Johanna Chief Commercial Officer Sell 55.0 -148 -0.10% ✓ $2.2K
Mar 5, 2026 Mar 6, 2026 Kerr Douglas Chief Medical Officer Sell 50.6 -904 -0.52% ✓ $13.5K
Mar 5, 2026 Mar 6, 2026 Cox John CEO Sell 50.6 -2,732 -0.61% ✓ $40.7K
Feb 12, 2026 Feb 17, 2026 Cox John CEO Neutral 90.0 +180,000 66.95% ✗ -
Feb 12, 2026 Feb 17, 2026 Kerr Douglas Chief Medical Officer Neutral 90.0 +85,000 97.13% ✗ -
Feb 12, 2026 Feb 17, 2026 Friedl-Naderer Johanna Chief Commercial Officer Neutral 90.0 +60,000 63.34% ✗ -
Feb 12, 2026 Feb 17, 2026 Lucera Erick CFO Neutral 90.0 +65,000 98.34% ✗ -
Dec 22, 2025 Dec 23, 2025 Karnani Vikram Director Neutral 52.5 - 0.00% ✗ -
Dec 23, 2025 Karnani Vikram Director Neutral 52.5 - 0.00% ✗ -
Dec 5, 2025 Dec 5, 2025 Cox John CEO Sell 47.5 -2,662 -0.98% ✓ $55.2K
Dec 5, 2025 Dec 5, 2025 Kerr Douglas Chief Medical Officer Sell 51.3 -880 -1.00% ✓ $18.2K
Dec 5, 2025 Dec 5, 2025 Friedl-Naderer Johanna Chief Commercial Officer Sell 55.0 -144 -0.15% ✓ $3K
Oct 1, 2025 Oct 2, 2025 Posner Brian S Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2025 Posner Brian S Director Neutral 52.5 - 0.00% ✗ -
Sep 5, 2025 Sep 9, 2025 Cox John CEO Sell 51.3 -2,640 -0.96% ✓ $35.4K
Sep 4, 2025 Sep 8, 2025 Friedl-Naderer Johanna Chief Commercial Officer Sell 48.8 -1,038 -1.08% ✓ $13.8K
Sep 4, 2025 Sep 8, 2025 Kerr Douglas Chief Medical Officer Sell 37.5 -4,425 -4.77% ✓ $58.8K
Jul 16, 2025 Jul 18, 2025 Friedl-Naderer Johanna Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jul 16, 2025 Jul 18, 2025 Kerr Douglas Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jul 16, 2025 Jul 18, 2025 Cox John CEO Neutral 52.5 - 0.00% ✗ -
Jul 14, 2025 Jul 15, 2025 Cox John CEO Buy 97.5 +60,000 28.01% ✗ $911K
Jun 5, 2025 Jun 6, 2025 Cox John CEO Sell 41.3 -4,060 -2.28% ✓ $54.2K
Jun 5, 2025 Jun 6, 2025 Kerr Douglas Chief Medical Officer Sell 48.8 -1,342 -1.43% ✓ $17.9K
Jun 5, 2025 Jun 6, 2025 Friedl-Naderer Johanna Chief Commercial Officer Sell 55.0 -146 -0.15% ✓ $1.9K
May 30, 2025 Jun 3, 2025 HURWITZ EDWARD Director Neutral 52.5 - 0.00% ✗ -
May 30, 2025 Jun 3, 2025 Lubner David Charles Director Neutral 52.5 - 0.00% ✗ -
May 30, 2025 Jun 3, 2025 Rhodes Jason P Director Neutral 52.5 - 0.00% ✗ -
May 30, 2025 Jun 3, 2025 Kersten Dirk Director Neutral 52.5 - 0.00% ✗ -
May 30, 2025 Jun 3, 2025 Incerti Carlo Director Neutral 52.5 - 0.00% ✗ -
May 30, 2025 Jun 3, 2025 Stehman-Breen Catherine Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 1, 2025 Lucera Erick CFO Neutral 90.0 +66,100 100.00% ✗ -
Apr 1, 2025 Lucera Erick CFO Neutral 52.5 - 0.00% ✗ -
Mar 13, 2025 Mar 13, 2025 Friedl-Naderer Johanna Chief Commercial Officer Sell 55.0 -143 -0.15% ✓ $1.7K
Mar 11, 2025 Mar 13, 2025 Scalzo Richard William SVP, Head of Finance & Admin. Sell 48.8 -1,343 -1.09% ✓ $15.3K
Mar 11, 2025 Mar 13, 2025 Beskrovnaya Oxana Chief Scientific Officer Sell 48.8 -2,153 -1.09% ✓ $24.5K
Mar 5, 2025 Mar 7, 2025 Kerr Douglas Chief Medical Officer Sell 48.8 -1,343 -1.41% ✓ $15.9K
Mar 5, 2025 Mar 7, 2025 Cox John CEO Sell 45.0 -4,061 -2.23% ✓ $48K
Mar 5, 2025 Mar 7, 2025 Scalzo Richard William SVP, Head of Finance & Admin. Sell 51.3 -917 -0.74% ✓ $10.8K
Mar 5, 2025 Mar 7, 2025 Beskrovnaya Oxana Chief Scientific Officer Sell 51.3 -1,094 -0.55% ✓ $12.9K
Feb 18, 2025 Feb 25, 2025 Beskrovnaya Oxana Chief Scientific Officer Sell 48.8 -2,598 -1.29% ✓ $36.2K
Feb 18, 2025 Feb 18, 2025 Scalzo Richard William SVP, Head of Finance & Admin. Sell 48.8 -2,488 -1.96% ✓ $34.7K
Jan 27, 2025 Jan 29, 2025 Rhodes Jason P Director Neutral 90.0 +1,111,111 131.13% ✗ -
Dec 11, 2024 Dec 11, 2024 Beskrovnaya Oxana Chief Scientific Officer Sell 45.0 -2,334 -1.14% ✓ $65.6K
Dec 11, 2024 Dec 11, 2024 Scalzo Richard William SVP, Head of Finance & Admin. Sell 48.8 -1,455 -1.13% ✓ $40.9K
Dec 6, 2024 Dec 10, 2024 Kersten Dirk Director Sell 17.5 -136,112 -2.46% ✗ $4M
Dec 4, 2024 Dec 6, 2024 Friedl-Naderer Johanna Chief Commercial Officer Neutral 90.0 +37,800 64.73% ✗ -
Dec 4, 2024 Dec 6, 2024 Kersten Dirk Director Sell 17.5 -138,845 -2.45% ✗ $4.1M
Dec 4, 2024 Dec 6, 2024 Scalzo Richard William SVP, Head of Finance & Admin. Neutral 90.0 +32,700 34.12% ✗ -
Dec 4, 2024 Dec 6, 2024 Kerr Douglas Chief Medical Officer Neutral 90.0 +48,000 101.05% ✗ -
Dec 4, 2024 Dec 6, 2024 Cox John CEO Neutral 90.0 +145,300 392.70% ✗ -
Dec 4, 2024 Dec 6, 2024 Beskrovnaya Oxana Chief Scientific Officer Neutral 90.0 +66,500 48.36% ✗ -
Dec 2, 2024 Dec 4, 2024 Kersten Dirk Director Sell 17.5 -110,933 -1.92% ✗ $3.3M
Nov 18, 2024 Nov 18, 2024 Incerti Carlo Director Sell 20.0 -16,500 -100.00% ✗ $474K
Nov 14, 2024 Nov 18, 2024 Rhodes Jason P Director Sell 51.3 -782 -0.01% ✗ $25.9K
Nov 18, 2024 Nov 18, 2024 Scalzo Richard William SVP, Head of Finance & Admin. Sell 41.3 -2,735 -2.77% ✓ $77.1K
Nov 18, 2024 Nov 18, 2024 Beskrovnaya Oxana Chief Scientific Officer Sell 41.3 -2,856 -2.03% ✓ $80.5K
Nov 13, 2024 Nov 15, 2024 Kersten Dirk Director Sell 46.3 -19,732 -0.34% ✓ $673.7K
Oct 18, 2024 Oct 22, 2024 Kersten Dirk Director Sell 17.5 -13,535 -15.62% ✓ $475.9K
Oct 16, 2024 Oct 18, 2024 Kersten Dirk Director Sell 5.0 -36,684 -29.75% ✓ $1.3M
Oct 3, 2024 Oct 7, 2024 Kersten Dirk Director Sell 37.5 -5,441 -4.23% ✓ $191.1K
Oct 1, 2024 Oct 3, 2024 Kersten Dirk Director Sell 15.0 -29,941 -18.87% ✓ $1.1M
Sep 27, 2024 Oct 1, 2024 Kersten Dirk Director Sell 15.0 -30,974 -16.33% ✓ $1.1M
Sep 25, 2024 Sep 27, 2024 Kersten Dirk Director Sell 45.0 -3,617 -1.87% ✓ $127.1K
Sep 20, 2024 Sep 24, 2024 Kersten Dirk Director Sell 5.0 -120,242 -38.35% ✓ $4.3M
Sep 18, 2024 Sep 20, 2024 Kersten Dirk Director Sell 10.0 -80,293 -20.39% ✓ $2.9M
Sep 18, 2024 Sep 19, 2024 HIGH SUSANNA GATTI COO Sell 30.0 -8,976 -6.38% ✓ $308.9K
Sep 18, 2024 Sep 19, 2024 Scalzo Richard William SVP, Head of Finance & Admin. Sell 48.8 -1,390 -1.39% ✓ $48K
Sep 18, 2024 Sep 19, 2024 Beskrovnaya Oxana Chief Scientific Officer Sell 45.0 -2,339 -1.64% ✓ $80.8K
Sep 16, 2024 Sep 18, 2024 Kersten Dirk Director Sell 45.0 -4,592 -1.15% ✓ $161.2K
Sep 11, 2024 Sep 11, 2024 Beskrovnaya Oxana Chief Scientific Officer Sell 45.0 -2,161 -1.49% ✓ $68.9K
Sep 11, 2024 Sep 11, 2024 Scalzo Richard William SVP, Head of Finance & Admin. Sell 48.8 -1,468 -1.45% ✓ $46.8K
Sep 11, 2024 Sep 11, 2024 HIGH SUSANNA GATTI COO Sell 37.5 -5,270 -3.61% ✓ $168.1K
Sep 6, 2024 Sep 10, 2024 Scalzo Richard William SVP, Head of Finance & Admin. Sell 17.5 -126,074 -55.42% ✗ $4.1M
Sep 5, 2024 Sep 9, 2024 Kersten Dirk Director Sell 48.8 -1,577 -0.39% ✓ $55.2K
Sep 4, 2024 Sep 4, 2024 Cox John CEO Buy 100.0 +32,000 640.00% ✗ $1.1M
Aug 30, 2024 Sep 4, 2024 Kersten Dirk Director Sell 27.5 -31,300 -7.26% ✓ $1.4M
Sep 3, 2024 Sep 3, 2024 Kerr Douglas Chief Medical Officer Neutral 90.0 +47,500 100.00% ✗ -
Sep 3, 2024 Friedl-Naderer Johanna Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Sep 3, 2024 Sep 3, 2024 Friedl-Naderer Johanna Chief Commercial Officer Neutral 90.0 +58,400 100.00% ✗ -
Sep 3, 2024 Kerr Douglas Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Aug 28, 2024 Aug 30, 2024 Kersten Dirk Director Sell 8.8 -134,261 -23.74% ✓ $6M
Aug 26, 2024 Aug 28, 2024 Kersten Dirk Director Sell 8.8 -154,900 -21.50% ✓ $7M
Aug 22, 2024 Aug 26, 2024 Kersten Dirk Director Sell 8.8 -180,409 -20.03% ✓ $8.3M
Aug 20, 2024 Aug 22, 2024 Kersten Dirk Director Sell 12.5 -222,603 -19.81% ✓ $10.4M
Aug 19, 2024 Aug 20, 2024 Scalzo Richard William SVP, Head of Finance & Admin. Sell 41.3 -2,752 -2.42% ✓ $124.2K
Aug 19, 2024 Aug 20, 2024 McNeill Jonathan Chief Business Officer Sell 41.3 -2,705 -2.01% ✓ $122.1K
Aug 19, 2024 Aug 20, 2024 Farwell Wildon Chief Medical Officer Sell 45.0 -2,321 -1.59% ✓ $104.7K
Aug 19, 2024 Aug 20, 2024 HIGH SUSANNA GATTI COO Sell 45.0 -2,910 -1.96% ✓ $131.3K
Aug 19, 2024 Aug 20, 2024 Beskrovnaya Oxana Chief Scientific Officer Sell 45.0 -2,636 -1.79% ✓ $118.9K
Aug 16, 2024 Aug 20, 2024 Kersten Dirk Director Sell 12.5 -248,675 -18.12% ✓ $11.3M
Aug 14, 2024 Aug 16, 2024 Kersten Dirk Director Sell 12.5 -281,541 -17.03% ✓ $12.6M
Aug 12, 2024 Aug 14, 2024 Kersten Dirk Director Sell 18.8 -212,477 -11.39% ✓ $9.1M
Aug 8, 2024 Aug 14, 2024 Kersten Dirk Director Sell 22.5 -183,834 -8.97% ✓ $7.9M
Aug 8, 2024 Aug 12, 2024 Kersten Dirk Director Sell 35.0 -183,834 -2.86% ✓ $7.9M
Jun 21, 2024 Jul 3, 2024 HIGH SUSANNA GATTI COO Sell 20.0 -40,000 -11.85% ✓ $1.4M
Jun 21, 2024 Jun 24, 2024 HIGH SUSANNA GATTI COO Sell 20.0 -39,950 -11.84% ✓ $1.4M
Jun 12, 2024 Jun 13, 2024 HIGH SUSANNA GATTI COO Sell 10.0 -40,000 -21.19% ✓ $1.3M
Jun 11, 2024 Jun 11, 2024 Beskrovnaya Oxana Chief Scientific Officer Sell 45.0 -2,136 -1.43% ✓ $66.9K
Jun 11, 2024 Jun 11, 2024 Farwell Wildon Chief Medical Officer Sell 45.0 -2,636 -1.78% ✓ $82.4K
Jun 10, 2024 Jun 11, 2024 HIGH SUSANNA GATTI COO Sell 5.0 -85,270 -36.43% ✓ $2.6M